Prevalence of Fibromyalgia in Israel
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The prevalence of fibromyalgia syndrome in the Israeli population is of importance fro planning resource allocation of medical expenditure as well as for identifying demographic and ethnic differences of this unique population compared with other western samples. In the current study the investigators aim at estimating the prevalence of fibromyalgia in this population. For this purpose a two - stage process will be used. First, a population survey will be conducted by telephone, screening for widespread pain and fatigue in the general population. This survey will use the London Fibromyalgia Epidemiology Study Screening Questionnaire. Second, a sample of patients attending the rheumatology clinic will be surveyed with this tool and will be examined in order to determine the actual proportion of patients fulfilling ACR criteria for fibromyalgia. This will enable us to calculate the positive predictive value of the London Fibromyalgia Epidemiology Study Screening Questionnaire in our population and hence to calculate the prevalence of fibromyalgia in the population.
| Condition |
|---|
|
Fibromyalgia |
| Study Type: | Observational |
| Official Title: | Prevalence of Fibromyalgia in Israel |
- Prevalence of fibromyalgia in the Israeli population [ Time Frame: 9 months ] [ Designated as safety issue: No ]
- Demographic data on fibromyalgia patients [ Time Frame: 9 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1200 |
| Study Start Date: | October 2010 |
| Estimated Study Completion Date: | March 2012 |
| Estimated Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Telephone survey - general population over age 18 Rheumatology patients - patients attending the rheumatology clinic for any reason
Inclusion Criteria:
- Individuals over 18 who consent to answer the survey questions
Contacts and Locations| Contact: Jacob N Ablin, MD | 972-3-6973668 | jacobab@tasmc.health.gov.il |
| Israel | |
| Tel Aviv SOurasky Medical center | Recruiting |
| Tel Aviv, Israel | |
| Contact: Jacob N Ablin, MD 972-3-6973668 jacobab@tasmc.health.gov.il | |
| Principal Investigator: Jacob N Ablin, MD | |
| Principal Investigator: | Jacob N Ablin, MD | Tel-Aviv Sourasky Medical Center |
More Information
Publications:
| Responsible Party: | Tel-Aviv Sourasky Medical Center |
| ClinicalTrials.gov Identifier: | NCT01203865 History of Changes |
| Other Study ID Numbers: | 0303-10-TLV, WS573984 |
| Study First Received: | September 15, 2010 |
| Last Updated: | October 10, 2011 |
| Health Authority: | Israel: Ministry of Health |
Keywords provided by Tel-Aviv Sourasky Medical Center:
|
Fibromyalgia Fatigue |
Additional relevant MeSH terms:
|
Fibromyalgia Myofascial Pain Syndromes Muscular Diseases Musculoskeletal Diseases |
Rheumatic Diseases Neuromuscular Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on May 16, 2013